Overview

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

Status:
Completed
Trial end date:
2007-03-06
Target enrollment:
Participant gender:
Summary
This study was run to determine the safety, tolerance, and efficacy of multiple doses of larazotide acetate in subjects with celiac disease following a gluten challenge.
Phase:
Phase 2
Details
Lead Sponsor:
9 Meters Biopharma, Inc.
Alba Therapeutics